Greater Occipital Nerve Pulsed Radiofrequency in Cervicogenic Headache
GONPRFCEH
Efficacy of Greater Occipital Nerve Pulsed Radiofrequency Treatment at C2 Level in Cervicogenic Headache
2 other identifiers
interventional
25
1 country
1
Brief Summary
The effect of GON PRF treatment applied with USG-guided proximal technique in patients who do not respond to conservative treatments for cervicogenic headache
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
January 2, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2025
CompletedMarch 2, 2026
February 1, 2026
10 months
January 2, 2025
February 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analog Scale
Average headache severity, maximum headache severity, number of headache days (monthly) measured with a visual analog scale (VAS; 10-point VAS scoring, 0 being no pain and 10 being the highest pain intensity that can be tolerated)
3 months
Study Arms (1)
Clinical data of the patients before and after treatment will be compared
OTHERAccording to the International Classification of Headache Disorders (ICHD)-III diagnostic criteria, patients diagnosed with cervicogenic headache will undergo a proximal technique C2 level greater occipital nerve (GON) diagnostic block under ultrasound (USG) guidance, and patients with a positive response (≥50% reduction in pain or positive effect) will receive GON-PRF treatment with the same technique. This study mainly aims to evaluate the clinical efficacy and safety of GON PRF treatment applied at the C2 level under USG guidance in cervicogenic headache during the follow-up period. Our secondary aim is to determine the effects of the GON PRF treatment we applied on the analgesic drug consumption, daily life activities and sleep of the volunteers, how they generally perceive this treatment and whether there is a need for any additional treatment.
Interventions
GON PRF treatment, which we apply by imaging the target nerve and surrounding structures with the proximal technique (at C2 level) under USG guidance in patients who do not respond to conservative treatments for cervicogenic headache.
Ultrasound-guided pulsed radiofrequency treatment of the greater occipital nerve at the C2 level
Eligibility Criteria
You may qualify if:
- Diagnosed with cervicogenic headache according to ICHD-3 criteria
- Cranial and cervical spine imaging is available
- Number of headache days per month 5 and/or more
- Inadequate benefit from pharmacological treatments or physical therapy methods used
- Volunteer patients who can understand and approve the treatment and the informed consent form and who can comply with the treatment
You may not qualify if:
- History of secondary headache other than cervicogenic headache according to ICHD-3 criteria
- Cervical nerve root irritation and/or spinal stenosis symptoms and signs
- Sensory deficit findings in the greater occipital nerve dermatome
- Craniocervical defect or other anatomical abnormality in the target area or nearby the procedure
- Local or systemic infection
- Received nonpharmacological treatment within the last 3 months (physical therapy, botulinum toxin A, acupuncture, ozone, cognitive behavioral therapy, etc.)
- Pregnancy or suspected pregnancy
- Known allergy to local anesthetic drugs
- History of malignancy
- Known organic disease of the brain and spinal cord
- History of cranial/cervical surgery within the last 1 year
- Bleeding-clotting disorder or oral anticoagulant use
- Comorbid disease that may cause headache (uncontrolled hypertension, intracranial lesion, etc.)
- Compliance with treatment and treatment results diseases that may affect the evaluation (psychiatric disorder, dementia, etc.)
- Those who request re-treatment due to the emergence of contralateral pain or other types of pain during the follow-up period after treatment
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Sciences University, Ankara Bilkent City Hospital
Ankara, Cankaya, 06800, Turkey (Türkiye)
Related Publications (1)
Gabrhelik T, Michalek P, Adamus M. Pulsed radiofrequency therapy versus greater occipital nerve block in the management of refractory cervicogenic headache - a pilot study. Prague Med Rep. 2011;112(4):279-87.
PMID: 22142523RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assoc prof dr
Study Record Dates
First Submitted
January 2, 2025
First Posted
January 8, 2025
Study Start
March 1, 2023
Primary Completion
January 1, 2024
Study Completion
December 1, 2024
Last Updated
March 2, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
I dont want to.